Humanized HLA-DR4 mice fed with the protozoan pathogen of oysters Perkinsus marinus (Dermo) do not develop noticeable pathology but elicit systemic immunity.
Perkinsus marinus (Phylum Perkinsozoa) is a marine protozoan parasite responsible for "Dermo" disease in oysters, which has caused extensive damage to the shellfish industry and estuarine environment. The infection prevalence has been estimated in some areas to be as high as 100%, often causing death of infected oysters within 1-2 years post-infection. Human consumption of the parasites via infected oysters is thus likely to occur, but to our knowledge the effect of oral consumption of P. marinus has not been investigated in humans or other mammals. To address the question we used humanized mice expressing HLA-DR4 molecules and lacking expression of mouse MHC-class II molecules (DR4.EA(0)) in such a way that CD4 T cell responses are solely restricted by the human HLA-DR4 molecule. The DR4.EA(0) mice did not develop diarrhea or any detectable pathology in the gastrointestinal tract or lungs following single or repeated feedings with live P. marinus parasites. Furthermore, lymphocyte populations in the gut associated lymphoid tissue and spleen were unaltered in the parasite-fed mice ruling out local or systemic inflammation. Notably, naïve DR4.EA(0) mice had antibodies (IgM and IgG) reacting against P. marinus parasites whereas parasite specific T cell responses were undetectable. Feeding with P. marinus boosted the antibody responses and stimulated specific cellular (IFNγ) immunity to the oyster parasite. Our data indicate the ability of P. marinus parasites to induce systemic immunity in DR4.EA(0) mice without causing noticeable pathology, and support rationale grounds for using genetically engineered P. marinus as a new oral vaccine platform to induce systemic immunity against infectious agents.
US Military Malaria Vaccine Program, Naval Medical Research Center/Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Wathsala
W
Wijayalath
US Military Malaria Vaccine Program, Naval Medical Research Center/Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Sai
S
Majji
US Military Malaria Vaccine Program, Naval Medical Research Center/Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Yuliya
Y
Kleschenko
Department of Medicine, Uniformed Services University of Health Sciences, Bethesda, Maryland, United States of America.
Luis
L
Pow-Sang
Department of Medicine, Uniformed Services University of Health Sciences, Bethesda, Maryland, United States of America.
Teodor D
TD
Brumeanu
US Military Malaria Vaccine Program, Naval Medical Research Center/Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Eileen Franke
EF
Villasante
Department of Microbiology and Immunology, University of Maryland Baltimore School of Medicine, Baltimore, Maryland, United States of America.
Gerardo R
GR
Vasta
Department of Microbiology and Immunology, University of Maryland Baltimore School of Medicine, Baltimore, Maryland, United States of America.
José-Antonio
JA
Fernández-Robledo
US Military Malaria Vaccine Program, Naval Medical Research Center/Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America ; Department of Medicine, Uniformed Services University of Health Sciences, Bethesda, Maryland, United States of America.
Sofia
S
Casares
D056893:Alveolata / Q000276:immunology*; D000818:Animals; D015804:HLA-DR4 Antigen / Q000235:genetics / Q000276:immunology*; D006801:Humans; D007371:Interferon-gamma / Q000276:immunology; D051379:Mice; D008822:Mice, Transgenic; D010125:Ostreidae / Q000469:parasitology*; D012758:Shellfish / Q000469:parasitology*
D015804:HLA-DR4 Antigen; D007371:Interferon-gamma